East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective

Racial and regional differences exist in morbidity, histology, drug response, toxicity, and prognosis of gynecologic cancer. However, most large-scale phase III studies have been conducted in Western countries, and these data on Asians, who account for more than half of the world’s population, are l...

Descripción completa

Detalles Bibliográficos
Autores principales: Enomoto, Takayuki, Okamoto, Aikou, Kim, Jae-Hoon, Lai, Chyong-Huey, Wu, Xiaohua, Kim, Yong-Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2023
Materias:
Special Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482583/
https://www.ncbi.nlm.nih.gov/pubmed/37593814
http://dx.doi.org/10.3802/jgo.2023.34.e86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482583/
https://www.ncbi.nlm.nih.gov/pubmed/37593814
http://dx.doi.org/10.3802/jgo.2023.34.e86

Ejemplares similares